BioCentury
ARTICLE | Company News

PicoSeq, Hybrigenics, Ecole Normale Superieure, Bpifrance deal

June 8, 2015 7:00 AM UTC

The entities partnered to develop PicoSeq’s SIMDEQ single-molecule magnetic detection and quantification technology for detecting epigenetic signals from DNA. The project, called EPIGENETIX2, was selected for funding in the second phase of the French Worldwide Innovation Challenge. Hybrigenics will use its HybriBody screening platform to develop single-chain-fragment antibodies for use in SIMDEQ. Researchers at Ecole Normale Superieure (ENS) will contribute physics- and engineering-related support to SIMDEQ’s development. ...